These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2910236)

  • 21. Metastatic spread and "escape" from the immune defenses of the host.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response to a transplantable malignant melanoma in mice.
    Bartholomaeus WN; Bray AE; Papadimitriou JM; Keast D
    J Natl Cancer Inst; 1974 Oct; 53(4):1065-72. PubMed ID: 4547798
    [No Abstract]   [Full Text] [Related]  

  • 23. [The immunology of cancer].
    Tabbara WS
    J Med Liban; 1971; 24(3):209-26. PubMed ID: 5151404
    [No Abstract]   [Full Text] [Related]  

  • 24. Pineal influences on tumor.
    Lapin V
    Prog Brain Res; 1979; 52():523-33. PubMed ID: 232927
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approaches.
    Paillard F
    Hum Gene Ther; 2000 Mar; 11(5):657-8. PubMed ID: 10757345
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cancer and immunosuppression : experimental aspects].
    Maral J; Florentin I; Soubrane C; Maral R
    Bull Cancer; 1983; 70(5):351-71. PubMed ID: 6230125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods of immunosuppression for study of growth and lung colony formation by human tumor cells in mice.
    Kovnat A; Khoo K; Selby P; Tannock I
    Cancer Res; 1986 Apr; 46(4 Pt 1):1617-22. PubMed ID: 3512076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biologic and immunologic studies on a murine model of regional lymph node metastasis.
    Finlay-Jones JJ; Bartholomaeus WN; Fimmel PJ; Keast D; Stanley NF
    J Natl Cancer Inst; 1980 Jun; 64(6):1363-72. PubMed ID: 6929375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of immunosurveillance against chemically induced in situ tumors in mice.
    Andrews EJ
    J Natl Cancer Inst; 1974 Mar; 52(3):729-32. PubMed ID: 4826561
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Immune surveillance revisited.
    Kripke ML; Borsos T
    J Natl Cancer Inst; 1974 May; 52(5):1393-5. PubMed ID: 4831431
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity.
    Smyth MJ; Dunn GP; Schreiber RD
    Adv Immunol; 2006; 90():1-50. PubMed ID: 16730260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth of human tumours in immune-suppressed mice.
    Franks CR; Perkins FT; Holmes JT
    Proc R Soc Med; 1975 May; 68(5):287-90. PubMed ID: 1215415
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of wide field irradiation on unirradiated tumors in the same host.
    Copper JS; Bart RS; Kopf AW; Newall J
    Int J Radiat Oncol Biol Phys; 1977; 2(1-2):133-9. PubMed ID: 403162
    [No Abstract]   [Full Text] [Related]  

  • 35. Host resistance to cancer.
    Goldstein G
    Aust N Z J Surg; 1967 Feb; 36(3):238-42. PubMed ID: 5227488
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice.
    Stanbredge EJ; Boulger LR; Franks CR; Garrett JA; Reeson DE; Bishop D; Perkins FT
    Cancer Res; 1975 Aug; 35(8):2203-12. PubMed ID: 1080073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is immunosuppression at the tumor site mechanism of evasion of a systemic response?
    Karakousis CP; Sharma S; Brooks SP
    J Med; 2003; 34(1-6):3-14. PubMed ID: 17682306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor cell and host properties affecting the implantation and survival of blood-borne metastatic variants of B16 melanoma.
    Fidler IJ; Nicolson GL
    Isr J Med Sci; 1978 Jan; 14(1):38-50. PubMed ID: 632082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-specific immunity in the course of primary polyoma and Rous tumor development in intact and immunosuppressed rats.
    Sjögren HO; Borum K
    Cancer Res; 1971 Jun; 31(6):890-900. PubMed ID: 4326040
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.